Help | RSS Feed



IntelliPharmaCeutics International, Inc. (TSE:IPCI.TO) Seasonal Chart

Seasonal Chart Analysis

Analysis of the IntelliPharmaCeutics International, Inc. (TSE:IPCI.TO) seasonal charts above shows that a Buy Date of December 14 and a Sell Date of March 10 has resulted in a geometric average return of 11.95% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 43.57% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

IntelliPharmaCeutics International Inc is a pharmaceutical company. The Company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, pain. The company’s lead product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval.

To download IPCI.TO seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore